Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Atea Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 82 | 104 | +22 |
| Shares | 52.1M | 58.9M | +6.84M (+13.1%) |
| Value | $3.20B | $1.27B | −$1.94B (−60.5%) |
New holders (38)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (16)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Bain Capital Public Equity Management II, LLC | 847,208 | $52.3M |
| Bank Julius Baer & Co. Ltd, Zurich | 77,652 | $4.79M |
| Ameriprise Financial Inc | 62,365 | $3.85M |
| Ergoteles LLC | 50,362 | $3.11M |
| Laurion Capital Management LP | 45,000 | $2.78M |
| Millennium Management LLC | 32,420 | $2.00M |
| D. E. Shaw & Co., Inc. | 28,187 | $1.74M |
| California Public Employees Retirement System | 26,031 | $1.61M |
| Athanor Capital, LP | 15,109 | $933.0K |
| Parkwood LLC | 8,341 | $515.0K |
| Victory Capital Management Inc | 7,088 | $438.0K |
| Virtu Financial LLC | 5,626 | $347.0K |
| Dimensional Fund Advisors LP | 3,683 | $227.0K |
| SG Americas Securities, LLC | 2,119 | $131.0K |
| Bank of Montreal | 420 | $24.0K |
| International Assets Investment Management, LLC | 100 | $4.00K |